Patient-oriented pandemic influenza research

The Lancet

Volumn 373, Issue 9681, 2009, Pages 2085-2086

  Hien, Tran Tinh ^a,b   Ruiz Palacios, Guillermo M ^c   Hayden, Frederick G ^b,d   Farrar, Jeremy ^a,b,e  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b South East Asia Infectious Diseases Clinical Research Network ^*  (Viet Nam)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d UNIVERSITY OF VIRGINIA   (United States)

^e OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; PERAMIVIR; ZANAMIVIR;

ARTICLE; CLINICAL RESEARCH; DRUG FORMULATION; HEALTH EDUCATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; PANDEMIC; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION; VIRUS MUTATION; VIRUS TRANSMISSION;

EID: 67449103926     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61131-4     Document Type: Note

References (6)

1. WHO. Influenza A (H1N1)-update 49. http://www.who.int/csr/don/2009_05_29/en/index.html (accessed June 16, 2009).
2. Fraser C., Donnelly C.A., Cauchemez S., et al., for the WHO Rapid Pandemic Assessment Collaboration. Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 10.1126/science.1176062 published online May 11.
3. Centers for Disease Control and Prevention. Hospitalized patients with novel influenza A (H1N1) virus infection-California, April-May, 2009. MMWR Morb Mortal Wkly Rep 58 (2009) 536-541
4. WHO. Weekly epidemiological record. http://www.who.int/wer/2009/wer8423.pdf (accessed June 11, 2009).
5. Hayden F.G. Perspectives on antiviral use during pandemic influenza. Phil Trans R Soc Lond B 356 (2001) 1877-1884
6. WHO. Clinical management of human infection with avian influenza A (H5N1) virus. http://www.who.int/csr/disease/avian_influenza/guidelines/clinicalmanage 07/en/index.html (accessed June 1, 2009).